A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma

Matthew J. Cortesea Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, OH, USA

Wei Weib Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Lerner Research Institute, Cleveland, OH, USA

Sebastian Cerdeñac Barnes-Jewish Hospital, Washington University in St. Louis, St. Louis, MO, USA

Marcus P. Watkinsc Barnes-Jewish Hospital, Washington University in St. Louis, St. Louis, MO, USA

Marissa Olsonc Barnes-Jewish Hospital, Washington University in St. Louis, St. Louis, MO, USA

Gray Jodond University of Colorado Cancer Center, Aurora, CO, USA

Jeff Kaiserd University of Colorado Cancer Center, Aurora, CO, USA

Bradley Haverkosd University of Colorado Cancer Center, Aurora, CO, USA

Mitchell E. Hughese Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA

Esin Namoglue Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA

Natalie S. Groverf Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA

Anson Snowf Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA

Victor Orellana-Noiag Division of Hematology/Oncology, University of Virginia, Charlottesville, VA, USA

Magdalena Raineyh Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, USA

Mohammad Sohailh Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, USA

Joslyn Rudonii Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA

Craig Portellg Division of Hematology/Oncology, University of Virginia, Charlottesville, VA, USA

Timothy Voorheesf Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA

Daniel J. Landsburge Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA

Manali Kamdard University of Colorado Cancer Center, Aurora, CO, USA

Brad S. Kahlc Barnes-Jewish Hospital, Washington University in St. Louis, St. Louis, MO, USA

Brian T. Hilla Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, OH, USACorrespondence[email protected]

Your download is now in progress and you may close this window